1 Answers
Nevirapine is indicated for combination antiretroviral treatment of HIV infection in adults and in pediatric patients 15 days and older.
Additional important information regarding the use of Nevirapine for the treatment of HIV infection:
- Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, Nevirapine should not be initiated in adult females with CD4+ cell counts greater than 250 cells/mm³ or in adult males with CD4+ cell counts greater than 400 cells/mm³ unless the benefit outweighs the risk.
- The 14-day lead-in period with Nevirapine 200 mg daily dosing must be strictly followed; it has been demonstrated to reduce the frequency of rash.
- If rash persists beyond the 14-day lead-in period, do not dose escalate to 200 mg twice daily. The 200 mg once-daily dosing regimen should not be continued beyond 28 days, at which point an alternative regimen should be sought.
Nevira Tablet সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Nevira
3283 views
Answered